Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1.

Proudnikov D, Kroslak T, Sipe JC, Randesi M, Li D, Hamon S, Ho A, Ott J, Kreek MJ.

Pharmacogenomics J. 2010 Jun;10(3):232-42. doi: 10.1038/tpj.2009.59. Epub 2009 Dec 15.

2.

Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome.

Jiang Y, Nie Y, Li Y, Zhang L.

J Gastroenterol Hepatol. 2014 Jun;29(6):1186-91. doi: 10.1111/jgh.12513.

PMID:
24444427
3.

Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.

Monteleone P, Bifulco M, Di Filippo C, Gazzerro P, Canestrelli B, Monteleone F, Proto MC, Di Genio M, Grimaldi C, Maj M.

Genes Brain Behav. 2009 Oct;8(7):728-32. doi: 10.1111/j.1601-183X.2009.00518.x. Epub 2009 Jun 26.

4.

Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.

Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE.

Addiction. 2008 Oct;103(10):1678-86. doi: 10.1111/j.1360-0443.2008.02292.x. Epub 2008 Aug 14.

5.

Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.

Monteleone P, Bifulco M, Maina G, Tortorella A, Gazzerro P, Proto MC, Di Filippo C, Monteleone F, Canestrelli B, Buonerba G, Bogetto F, Maj M.

Pharmacol Res. 2010 May;61(5):400-4. doi: 10.1016/j.phrs.2010.01.002. Epub 2010 Jan 18.

PMID:
20080186
6.

Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems.

Bidwell LC, Metrik J, McGeary J, Palmer RH, Francazio S, Knopik VS.

J Stud Alcohol Drugs. 2013 Nov;74(6):867-78.

7.

Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes.

Proudnikov D, LaForge KS, Hofflich H, Levenstien M, Gordon D, Barral S, Ott J, Kreek MJ.

Pharmacogenet Genomics. 2006 Jan;16(1):25-36.

PMID:
16344719
8.

The genetic basis of the endocannabinoid system and drug addiction in humans.

López-Moreno JA, Echeverry-Alzate V, Bühler KM.

J Psychopharmacol. 2012 Jan;26(1):133-43. doi: 10.1177/0269881111416689. Epub 2011 Sep 21. Review.

PMID:
21937688
9.

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.

Clarke TK, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Genes Brain Behav. 2012 Jun;11(4):415-23. doi: 10.1111/j.1601-183X.2012.00785.x. Epub 2012 Apr 11.

10.

Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction.

Proudnikov D, Hamon S, Ott J, Kreek MJ.

Neurosci Lett. 2008 Apr 25;435(3):234-9. doi: 10.1016/j.neulet.2008.02.042. Epub 2008 Feb 26.

11.

Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues.

Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE.

Neuropsychopharmacology. 2010 Mar;35(4):967-75. doi: 10.1038/npp.2009.200. Epub 2009 Dec 9.

12.

Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.

Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D, Onaivi ES, Arinami T, Uhl GR.

Mol Psychiatry. 2004 Oct;9(10):916-31.

PMID:
15289816
13.

Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.

Monteleone P, Milano W, Petrella C, Canestrelli B, Maj M.

J Clin Psychopharmacol. 2010 Aug;30(4):441-5. doi: 10.1097/JCP.0b013e3181e742c5.

PMID:
20631561
14.

[Association study of CNR1, GAD1 and BDNF polymorphisms with male heroin dependence in the Dai population in Yunnan].

Yang Y, Chen Y, Wu J, Xing Y, Zeng F, Huang Y, Cheng BW.

Yi Chuan. 2014 Sep;36(9):888-96. doi: 10.3724/SP.J.1005.2014.0888. Chinese.

PMID:
25252306
15.

Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.

Clarke TK, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Addict Biol. 2013 Jul;18(4):702-8. doi: 10.1111/j.1369-1600.2011.00346.x. Epub 2011 Jul 25.

16.

Cannabinoid receptor gene (CNR1): association with i.v. drug use.

Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G, MacMurray J.

Mol Psychiatry. 1997 Mar;2(2):161-8.

PMID:
9106242
17.

Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts.

Nielsen DA, Hamon S, Yuferov V, Jackson C, Ho A, Ott J, Kreek MJ.

Hum Genet. 2010 Jun;127(6):639-49. doi: 10.1007/s00439-010-0807-6. Epub 2010 Mar 18.

18.

The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction.

Flanagan JM, Gerber AL, Cadet JL, Beutler E, Sipe JC.

Hum Genet. 2006 Nov;120(4):581-8. Epub 2006 Sep 14.

PMID:
16972078
19.

No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population.

Li T, Liu X, Zhu ZH, Zhao J, Hu X, Ball DM, Sham PC, Collier DA.

Mol Psychiatry. 2000 Mar;5(2):128-30. No abstract available.

PMID:
10822338
20.

Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1.

Hancock DB, Levy JL, Gaddis NC, Glasheen C, Saccone NL, Page GP, Hulse GK, Wildenauer D, Kelty EA, Schwab SG, Degenhardt L, Martin NG, Montgomery GW, Attia J, Holliday EG, McEvoy M, Scott RJ, Bierut LJ, Nelson EC, Kral AH, Johnson EO.

Biol Psychiatry. 2015 Oct 1;78(7):474-84. doi: 10.1016/j.biopsych.2015.01.003. Epub 2015 Jan 29.

Supplemental Content

Support Center